Kuala Lumpur (PRWEB) September 24, 2008
Synamatix today announced its partnership with GeneWorks for the provision of sequencing and bioinformatics research support to key customers within Asia and Australia. The collaborative partnership was formalised soon after the launch of Synamatix's SynaWorks bioinformatics programme on 19 July 2008 at the Intelligent Systems for Molecular Biology conference in Toronto, Canada.
The two companies will provide genome institutes in Asia with an extensive and comprehensive range of sequencing and bioinformatics solutions to support and enhance research. The first project to be generated by the partnership is an initiative covering the de novo sequencing of microbial organisms.
The partnership will see GeneWorks provide next-generation sequencing services and know-how, with Synamatix delivering an array of bioinformatics analysis tasks under its SynaWorks programme. SynaWorks leverages the company's extensive pipeline of proprietary bioinformatics solutions for processing, mining, analysing and visualising data generated from 454 and Illumina sequencing platforms.
According to Synamatix General Manager, Dr Arif Anwar, "Development of SynaWorks started in early 2006, when we partnered leading genome institutes, such as the Washington University Genome Sequencing Center, in testing and analysing data generated from beta versions of the 454 platform. From this starting point, we have gained valuable knowledge on how best to manage next-generation data and significantly reduce error margins commonly associated with such platforms."
Peter Guilhaus, Managing Director of GeneWorks, stated, "We are pleased to be working with Synamatix on various de novo sequencing projects. By combining our expertise gained as a service provider utilising Illumina's Genome Analyzer Systems with Synamatix's bioinformatics capabilities, we feel that the partnership can effectively deliver best-of-breed solutions to our customers. Even the smallest lab can access our combined services to run very powerful experiments once limited to large genome centres."
It is envisaged that the collaboration will provide effective support especially to small and medium-sized research institutions, by enabling scientists to enhance and accelerate their research without being limited by a lack of bioinformatics resources or capabilities.
The fundamental technology underlying Synamatix R&D is the proprietary "SynaBASE™" platform. Applications built upon this database platform exhibit significant improvement in analysis scalability, sensitivity and performance. Synamatix is a privately held bioinformatics company whose primary activities are ongoing R&D related to its core technology, and the support of its user base in the USA, Europe, Asia and Australia.
GeneWorks Pty Ltd, established in 1996, is a major Australian supplier of leading-edge molecular biology research products. Centrally headquartered in Adelaide, South Australia with sales offices in all Australian key cities as well as Auckland NZ, GeneWorks services and supplies the Australian and New Zealand markets with a select range of innovative leading edge equipment, reagents, consumables and associated services. The company's core service business comprises the synthesis and supply of custom oligonucleotides and genome analysis services utilizing next generation systems from Illumina.